Serum ferritin as an independent risk factor for severity in COVID-19 patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum ferritin as an independent risk factor for severity in COVID-19 patients

Published:2020-10 Issue:4 Volume:81 Page:647-679
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Lin Zhi,Long Fei,Yang Yong,Chen Xiangyu,Xu Linyong,Yang Minghua

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference9 articles.

1. Serum amyloid A is a biomarker of severe coronavirus disease and poor prognosis;Li;J Infect,2020

2. Risk Factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China;Wu;JAMA Intern Med,2020

3. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis;Henry;Clin Chem Lab Med,2020

4. Serum ferritin as a predictor of the acute respiratory distress syndrome;Connelly;Am J Respir Crit Care Med,1997

5. Variation in iron homeostasis genes between patients with ARDS and healthy control subjects;Lagan;Chest,2008

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Increase in Aspartate Aminotransferase Can Predict Worsening Disease Severity in Japanese Patients with COVID-19;Clinics and Practice;2024-08-20

2. Interleukin-6 and Biomarkers Predict Outcomes in People with Diabetes and COVID-19 Infection;Medical Journal of Babylon;2024-06

3. Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning;PLOS ONE;2024-05-30

4. Pulmonary redox imbalance drives early fibroproliferative response in moderate/severe coronavirus disease-19 acute respiratory distress syndrome and impacts long-term lung abnormalities;Annals of Intensive Care;2024-05-12

5. Inflammatory Biomarkers for Assessing In-Hospital Mortality Risk in Severe COVID-19—A Retrospective Study;Journal of Personalized Medicine;2024-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3